Condition (MeSH)
Stomatitis, Denture
ClinicalTrials.gov lists 21 trials for Stomatitis, Denture or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
21 of the 21 trials are tagged with Stomatitis, Denture itself; the rest are tagged with a narrower condition beneath it.
When did Stomatitis, Denture trials start? (11)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 3
- Not applicable
- Observational
Top of scale: 8
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2023 | 3 |
| 2022 | 1 |
| 2018 | 1 |
| 2016 | 8 |
| 2012 | 1 |
| 2011 | 1 |
| 2010 | 2 |
| 2009 | 1 |
Showing 10 of 11 earlier years.
No forecast is made for this condition: it averages 1.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 21 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Stomatitis, Denture trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 4 |
| Phase 3 | 1 |
| Not applicable | 10 |
| Observational | 4 |
How many Stomatitis, Denture trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Completed | 14 |
| Unknown status | 6 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which drugs are being tested for Stomatitis, Denture? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Nystatin | 3 |
| Propolis | 1 |
| Miconazole | 1 |
Interventions as named in the registry (9)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| garlic , nystatin | 1 |
| Antimicrobial agent | 1 |
| Chlorhexidine mouthwash | 1 |
| Clotrimazole varnish | 1 |
| Denture soaking solution | 1 |
Showing 5 of 9 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Stomatitis, Denture? (29)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Efficacy of photodynamic therapy versus local nystatin in the treatment of denture stomatitis: A randomized clinical study. | Photodiagnosis and photodynamic therapy | 2019 | Yes |
| Improving practice guidelines for the treatment of denture-related erythematous stomatitis: a study protocol for a randomized controlled trial. | Trials | 2017 | Yes |
| Antifungal Activity of Apple Cider Vinegar on Candida Species Involved in Denture Stomatitis. | Journal of prosthodontics : official journal of the American College of Prosthodontists | 2015 | Yes |
| 10-year survival rate and the incidence of peri-implant disease of 374 titanium dental implants with a SLA surface: a prospective cohort study in 177 fully and partially edentulous patients. | Clinical oral implants research | 2015 | Yes |
| Epidemiology and etiology of denture stomatitis. | Journal of prosthodontics : official journal of the American College of Prosthodontists | 2011 | Yes |
Showing 5 of 29 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.